Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.93 |
| ▸ | EYA2 | O00167 | 1/20 | 0.93 |
| ▸ | APP | P05067 | 1/20 | 0.93 |
| ▸ | ACE | P12821 | 1/20 | 0.93 |
| ▸ | BLM | P54132 | 2/20 | 0.88 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.88 |
| ▸ | TSHR | P16473 | 2/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.88 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.88 |
| ▸ | LMNA | P02545 | 1/20 | 0.88 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.88 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.88 |
| ▸ | DRD1 | P21728 | 1/20 | 0.88 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.88 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.88 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.88 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.88 |
| ▸ | DRD3 | P35462 | 1/20 | 0.88 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.88 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL2342790 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL11876563 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1373 | 0.97 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8624198 | 0.97 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL16714076 | 0.97 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL15136 | 0.97 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8607480 | 0.97 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL3035039 | 0.97 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL16268141 | 0.93 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6265233 | 0.93 | TDP1 (0.93) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0200323-B1 | ORAL HYGIENE COMPOSITION | BEECHAM GROUP PLC (GB) | 1992-05-20 | — | — | EP | claimed |
| EP-0079611-A2 | Oral compositions containing strontium EDTA complex and soluble fluoride | Richardson-Vicks, Inc. (US) | 1983-05-25 | — | — | EP | claimed |
| US-20230255857-A1 | DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS | SHOFU INC. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-11648184-B2 | Dental composition containing ion sustained-release glass | SHOFU INC. (JP) | 2023-05-16 | — | — | US | disclosed |
| US-11559471-B2 | Dental composition containing ion sustained-release glass | SHOFU INC. (JP) | 2023-01-24 | — | — | US | disclosed |
| CN-110621286-A | Eco-friendly biofilm-disrupting antimicrobial formulations, development and use thereof | 阿里拉健康波士顿有限责任公司 | 2019-12-27 | — | — | CN | disclosed |
| EP-2949311-B1 | Dental composition containing ion sustained-release glass | SHOFU INC (JP) | 2019-10-16 | — | — | EP | disclosed |
| US-20180344579-A1 | DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS | SHOFU INC. (JP) | 2018-12-06 | — | — | US | disclosed |
| EP-2605744-B1 | ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE THEREOF | COLGATE PALMOLIVE CO (US) | 2017-11-01 | — | — | EP | disclosed |
| EP-2995312-A1 | ANTI-INFLAMMATORY COMPOSITION BASED ON STRONTIUM COMPOUNDS | SantoSolve AS (NO) | 2016-03-16 | — | — | EP | disclosed |
| US-20150342838-A1 | DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS | SHOFU INC. (JP) | 2015-12-03 | — | — | US | disclosed |
| EP-0311412-A2 | Anticalculus compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-12 | — | — | EP | disclosed |
| EP-0265186-A2 | Anticalculus compositions | THE PROCTER & GAMBLE COMPANY (US) | 1988-04-27 | — | — | EP | disclosed |
| EP-0233059-A2 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1987-08-19 | — | — | EP | disclosed |
| EP-0079611-A3 | ORAL COMPOSITIONS CONTAINING STRONTIUM EDTA COMPLEX AND SOLUBLE FLUORIDE | Richardson-Vicks, Inc. (US) | 1984-07-04 | — | — | EP | disclosed |
| EP-0079611-A3 | ORAL COMPOSITIONS CONTAINING STRONTIUM EDTA COMPLEX AND SOLUBLE FLUORIDE | Richardson-Vicks, Inc. (US) | 1984-07-04 | — | — | EP | disclosed |
| EP-0079611-A2 | Oral compositions containing strontium EDTA complex and soluble fluoride | Richardson-Vicks, Inc. (US) | 1983-05-25 | — | — | EP | disclosed |
| EP-0079611-A2 | Oral compositions containing strontium EDTA complex and soluble fluoride | Richardson-Vicks, Inc. (US) | 1983-05-25 | — | — | EP | disclosed |
| EP-0079611-A2 | Oral compositions containing strontium EDTA complex and soluble fluoride | Richardson-Vicks, Inc. (US) | 1983-05-25 | — | — | EP | disclosed |
| US-3988434-A | IONIC STRONTIUM CHELATE OF ETHYLENEDIAMINETETRAACETIC ACID | SCHOLE MURRAY L | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255857-A1 | DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS | SLCO2B1, CA2, SLCO2A1 | TDP1 4656/4885EYA2 4393/4885APP 3780/4885 |
| US-11559471-B2 | Dental composition containing ion sustained-release glass | SLCO2B1, CA2, SLCO2A1 | TDP1 4656/4885EYA2 4393/4885APP 3780/4885 |
| US-11648184-B2 | Dental composition containing ion sustained-release glass | SLCO2B1, CA2, SLCO2A1 | TDP1 4656/4885EYA2 4393/4885APP 3780/4885 |
| US-20180344579-A1 | DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS | SLCO2B1, CA2, SLCO2A1 | TDP1 4656/4885EYA2 4393/4885APP 3780/4885 |
| US-20150342838-A1 | DENTAL COMPOSITION CONTAINING ION SUSTAINED-RELEASE GLASS | SLCO2B1, CA2, SLCO2A1 | TDP1 4656/4885EYA2 4393/4885APP 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.